Inventor

MIYAKAWA TOMOYA

JP15 patents

⚠️ This page may combine multiple inventors who share the name “MIYAKAWA TOMOYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CYTLIMIC INC

8 patents

US10842848B2Nov 24, 2020

Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein

CYTLIMIC INC2 citations69

US11304997B2Apr 19, 2022

HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell

CYTLIMIC INC0 citations60

US11491204B2Nov 8, 2022

Composition comprising poly I:C and LAG-3-IGG fusion protein

CYTLIMIC INC0 citations59

US11291718B2Apr 5, 2022

Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

CYTLIMIC INC0 citations59

US10875900B2Dec 29, 2020

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

CYTLIMIC INC0 citations50

US10590179B2Mar 17, 2020

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

CYTLIMIC INC0 citations50

US10537626B2Jan 21, 2020

HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

CYTLIMIC INC0 citations50

US10526388B2Jan 7, 2020

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells

CYTLIMIC INC0 citations50

NEC CORP

4 patents

US12448413B2Oct 21, 2025

HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

NEC CORP0 citations61

US11618770B2Apr 4, 2023

MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same

NEC CORP0 citations61

US11759518B2Sep 19, 2023

Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

NEC CORP0 citations59

US9353151B2May 31, 2016

HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide

NEC CORP1 citations50

MIYAKAWA TOMOYA

3 patents

US9045531B2Jun 2, 2015

HLA-binding peptide, precursor thereof, and DNA fragment and recombinant vector coding for said HLA-binding peptide

MIYAKAWA TOMOYA3 citations59

US8487076B1Jul 16, 2013

HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide

MIYAKAWA TOMOYA3 citations59

US8324345B2Dec 4, 2012

HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same

MIYAKAWA TOMOYA2 citations59